Index by author

March-April 2016; Volume 13,Issue 2

  1. Birzele, FABIAN

    1. Open Access
      Molecular Basis of Lung Tropism of Metastasis
      ULRICH H. WEIDLE, FABIAN BIRZELE, GWENDLYN KOLLMORGEN and RÜDIGER RÜGER
      Cancer Genomics & Proteomics March 2016, 13 (2) 129-139;

  2. Chang, CHUNG-MING

    1. Open Access
      GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification
      JI-DUNG LUO, YU-JIA CHANG, CHUNG-MING CHANG, JENG-FU YOU, PO-LI WEI and CHIUAN-CHIAN CHIOU
      Cancer Genomics & Proteomics March 2016, 13 (2) 141-150;

  3. Chang, YU-JIA

    1. Open Access
      GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification
      JI-DUNG LUO, YU-JIA CHANG, CHUNG-MING CHANG, JENG-FU YOU, PO-LI WEI and CHIUAN-CHIAN CHIOU
      Cancer Genomics & Proteomics March 2016, 13 (2) 141-150;

  4. Chen, XUAN

    1. Open Access
      Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
      XUAN CHEN, YUE LIU, JIAN WU, HUARONG HUANG, ZHIYUN DU, KUN ZHANG, DAIYING ZHOU, KAYLYN HUNG, SUSAN GOODIN and XI ZHENG
      Cancer Genomics & Proteomics March 2016, 13 (2) 151-160;

  5. Chiou, CHIUAN-CHIAN

    1. Open Access
      GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification
      JI-DUNG LUO, YU-JIA CHANG, CHUNG-MING CHANG, JENG-FU YOU, PO-LI WEI and CHIUAN-CHIAN CHIOU
      Cancer Genomics & Proteomics March 2016, 13 (2) 141-150;

  6. Drozd, EWA

    1. Open Access
      Doxorubicin Treatment of Cancer Cells Impairs Reverse Transcription and Affects the Interpretation of RT-qPCR Results
      EWA DROZD, JOLANTA KRZYSZTOŃ-RUSSJAN and BEATA GRUBER
      Cancer Genomics & Proteomics March 2016, 13 (2) 161-170;

  7. Du, ZHIYUN

    1. Open Access
      Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
      XUAN CHEN, YUE LIU, JIAN WU, HUARONG HUANG, ZHIYUN DU, KUN ZHANG, DAIYING ZHOU, KAYLYN HUNG, SUSAN GOODIN and XI ZHENG
      Cancer Genomics & Proteomics March 2016, 13 (2) 151-160;

  8. Goodin, SUSAN

    1. Open Access
      Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
      XUAN CHEN, YUE LIU, JIAN WU, HUARONG HUANG, ZHIYUN DU, KUN ZHANG, DAIYING ZHOU, KAYLYN HUNG, SUSAN GOODIN and XI ZHENG
      Cancer Genomics & Proteomics March 2016, 13 (2) 151-160;

  9. Gruber, BEATA

    1. Open Access
      Doxorubicin Treatment of Cancer Cells Impairs Reverse Transcription and Affects the Interpretation of RT-qPCR Results
      EWA DROZD, JOLANTA KRZYSZTOŃ-RUSSJAN and BEATA GRUBER
      Cancer Genomics & Proteomics March 2016, 13 (2) 161-170;

  10. Huang, HUARONG

    1. Open Access
      Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
      XUAN CHEN, YUE LIU, JIAN WU, HUARONG HUANG, ZHIYUN DU, KUN ZHANG, DAIYING ZHOU, KAYLYN HUNG, SUSAN GOODIN and XI ZHENG
      Cancer Genomics & Proteomics March 2016, 13 (2) 151-160;
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue